Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J2Y5 | ISIN: US74621T2096 | Ticker-Symbol: IVMB
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
PURE BIOSCIENCE INC Chart 1 Jahr
5-Tage-Chart
PURE BIOSCIENCE INC 5-Tage-Chart

Aktuelle News zur PURE BIOSCIENCE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiPURE BIOSCIENCE, INC. - 8-K, Current Report1
18.03.PURE Bioscience GAAP EPS of -$0.01, revenue of $0.33M1
18.03.PURE BIOSCIENCE, INC. - 10-Q, Quarterly Report1
18.03.PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results53EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported...
► Artikel lesen
18.03.PURE BIOSCIENCE, INC. - 8-K, Current Report1
26.02.PURE BIOSCIENCE, INC. - 8-K, Current Report1
14.12.23PURE Bioscience GAAP EPS of -$0.01, revenue of $0.72M 1
14.12.23PURE BIOSCIENCE, INC. - 10-Q, Quarterly Report1
14.12.23PURE BIOSCIENCE, INC. - 8-K, Current Report1
14.12.23PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results155EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported...
► Artikel lesen
30.10.23PURE Bioscience GAAP EPS of -$0.04, revenue of $1.87M1
30.10.23PURE BIOSCIENCE, INC. - 10-K, Annual Report1
30.10.23PURE BIOSCIENCE, INC. - 8-K, Current Report1
30.10.23PURE Bioscience Reports Fiscal 2023 Financial Results148EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported...
► Artikel lesen
14.06.23PURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial Results223RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1